Search

Home > The Bio Report > Programming Cell Therapies to Overcome Solid Tumor Defense Systems
Podcast: The Bio Report
Episode:

Programming Cell Therapies to Overcome Solid Tumor Defense Systems
Category: Business
Duration: 00:28:28
Publish Date: 2021-09-16 08:00:26
Description: While CAR-T cell therapies have emerged as promising anti-cancer agents, their success have been focused on hematologic cancers. Arsenal Bio is working to develop more robust cell therapies capable to treating a broader range of cancers by using synthetic biology to make them programable. We spoke to Ken Drazen, CEO of Arsenal Bio, about the company’s next-generation T cell therapies, how it is able to program functions into these cells to overcome solid tumor defenses, and the company’s collaboration with Bristol-Myers Squibb announced at the start of the year.
Total Play: 0

Some more Podcasts by Levine Media Group

600+ Episodes
The Bio Repo ..